Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up News March 2008

Executive Summary

Noteworthy news from medtech start-ups, including Angel Medical's implantable early warning system for heart attacks and Innovent Medical's non-invasive device to prevent ventilator-associated pneumonia in the ICU.

You may also be interested in...



Hospital-Acquired Conditions: Patient Safety Concerns Fuel Device Innovation

New federal initiatives to improve patient safety are taking direct aim at hospitals' bottom line by making them bear the increased costs of treatment when patients acquire a condition deemed reasonably preventable. At this year's meeting of the Association of Operating Room Nurses, companies showcased new technologies designed to help hospitals avoid so-called "never events" like leaving objects in a patient after surgery, pressure ulcers acquired during a patient's stay, and certain nosocomial infections.

Hospital-Acquired Conditions: Patient Safety Concerns Fuel Device Innovation

New federal initiatives to improve patient safety are taking direct aim at hospitals' bottom line by making them bear the increased costs of treatment when patients acquire a condition deemed reasonably preventable. At this year's meeting of the Association of Operating Room Nurses, companies showcased new technologies designed to help hospitals avoid so-called "never events" like leaving objects in a patient after surgery, pressure ulcers acquired during a patient's stay, and certain nosocomial infections.

Innovent Medical Solutions Ltd.

Ventilator associated pneumonia (VAP), the second most common infection in the ICU, is caused when infected secretions that accumulate in and around the endotracheal tube leak into the lungs. Innovent Medical Solutions Ltd. intends to reduce both the incidence and the cost of treating VAP with noninvasive technology that mimics nature's own method for clearing airways: the cough. T In addition to decreasing the number of VAP cases by 50%, the company thinks its technology will also facilitate more use of noninvasive facemask ventilation, leading to an improvement in the quality of life for ICU patients.

Topics

Related Companies

UsernamePublicRestriction

Register

OM002075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel